INTRODUCTION
of venomous snakes, human population density, economic activities, and types of dwellings (3, 5) .
Turkey encompasses a wide range of geographically distinct regions and a large number of medically important snake species have been reported in the country (6) . Specifically, the most abundant species in Turkey belong to the following families: Acrochordidae, Viperidae, Elapidae and Colubridae (6) (7) (8) . In rural areas, snake envenomations are mainly associated with members of the Viperidae family (9, 10) .
The aim of the present study was to classify and characterize snakebites reported to the National Poison Information Center (NPIC) between 1995 and 2004, regarding epidemiology and clinical symptomatology.
PATIENTS AND METHODS

Geographic Area
The countries that border Turkey are Iraq, Iran and Syria on the southeast, Armenia and Georgia on the east and Greece and Bulgaria on the west (11) . Records of snake envenomation cases were obtained from throughout the country. Turkey provinces are organized into seven censusdefined regions for statistical purposes.
Data Collection
NPIC, created in 1986, is accessible 24 hours a day, 7 days a week. Clinicians in Turkey that treat snakebite victims are required to report these accidents to NPIC. In the current study, only cases involving snake envenomations available in NPIC database and recorded between 1995 and 2004 were investigated.
Epidemiological and Clinical Data
As aforementioned, metadata were obtained from NPIC. Patients were classified according to age, gender, incident date, geographic area, admission to healthcare facilities, clinical symptoms (local and systemic), general condition and therapeutic approach.
Clinical Classification of Cases
Clinical classification was based on recordings submitted by local physicians. Patients were divided into two major groups according to their symptoms. The local envenomation group included victims that presented local pain, hyperemia, burning and itching, while symptoms of the systemic envenomation group comprised ecchymosis, nausea, vomiting, hypotension, paresthesia and generalized edema among others. Meta data on clinical symptoms, administered therapeutic interventions including antivenom administration and other agents were analyzed. Within this group patients were subdivided to groups of moderate and severe envenomation. Moderate envenomation patients had mostly local and some systemic effects including sweating, 
RESULTS
From 1995 to 2004, 129,548 envenomation cases of various origins were reported in Turkey, of this total 1,929 involved animal bites or stings, of which 550 comprised snakebites.
Epidemiological Data
The reports of snakebites were from all Turkish regions. The ratio of incidents per geographic region is presented in Figure 1 (in percent). Snakebites were more frequent in the northwest region, also known as Marmara (n = 125), followed by Central Anatolia region (n = 123) and Black Sea region (n = 104). Marmara, despite its relatively small territory (8.5% of Turkey), is the most densely populated region of the country.
Accidents were more common during the summer (61.6%). The monthly distribution of snakebites is graphically demonstrated in Figure  2 , showing a clear peak in early summer with 24.3% of the incidents occurring in June.
The affected population had a male/female ratio of 1.29. Age distribution of victims is displayed in Table 1 , with the age group from 20 to 29 years old (21.6% of all patients) being the most afflicted. The majority of the victims (95.6%) arrived at local healthcare facilities or hospitals in less than one hour after the snakebite (Table 1) . Figure 3 presents the snake species mostly responsible for human envenomations in Turkey whereas Figure 4 displays clinical manifestations of the victims. Table 2 shows that local symptoms of envenomation were observed in 75.2% of the victims, including local edema (42.8%), local pain (30.4%), hyperemia (28.5%), and numbness (4.7%). Regarding systemic symptoms, the most frequent findings were: ecchymosis (7.6%); nausea and vomiting (6.6%); hypotension (3.8%); and paresthesia, generalized edema, tachycardia, dyspnea, cyanosis and dry mouth (1.9%). Occasionally convulsions, confusion, loss of consciousness, hyperthermia, hepatic failure and circulation failures, hematoma, drowsiness, epistaxis, chest and abdominal pain, venous spasm, thrombocytopenia and bradycardia (0.9%) were also observed. Most incidents involved moderate envenomation (53.3%), followed by mild (32.3%) and severe envenomation (11.4%), as shown in Table 2 . Treatment was based on symptomatic measures (34.2%), symptomatic approach with antivenom support (10.5%) and antivenom only (26.3%).
Clinical Assessment of Envenomation and Treatment
DISCUSSION
Up to our knowledge, the present work is the first epidemiological and clinical study on snake envenomation covering all geographic regions of Turkey. Analyzed NPIC records showed a total number of 550 snakebite cases during from 1995 to 2004. Interestingly, in the southeast region, the number of snakebite incidents was low compared to venomous scorpion stings (12) . Turkey has presents subtropical and semi-arid climates with extreme temperature range. Moreover, precipitation varies significantly from one region to another in the country (11) . Thus, it is difficult to correlate geographic features with reported snake envenomations. However, most bites by Vipera species occurred in rural areas (13) .
In Turkey, the most venomous snakes belong to the Acrochordidae and Viperidea families, Figure 3) . Additionally, other species from the Colubridae family were also classified as medically important in Turkey, such as Malpolon monspessulanus, Telescopus fallax and Telescopus nigriceps (6, (14) (15) (16) . Corroborating the literature from several countries, we found that the frequency of snakebites is higher in warmer periods of the year, peaking in June (2, 14, 17, 18) . This is not surprising, since snakes are more active during warm seasons. Also consistent with previous reports, in our study males (54.9%) and young adults (40%) were more affected by envenomations (5, 13, 14, (17) (18) (19) ). An interesting observation in the current study was that almost all patients (95%) actively sought medical help and a significant fraction (43.3%) reached a healthcare facility in less than one hour after the bite, which indicates that the population is aware of the serious consequences of snake envenomations.
The severity of venomous snakebites depends on several factors, including the bite site, the amount of injected venom, and the effectiveness of the initial therapy (20) . For instance, Vipera venom possesses a variety of biological activities, and once it is injected into an animal, it may reach the bloodstream within a minute, so that its components must achieve their effects at very low concentrations (20, 21) .
Snake venoms may exhibit both anticoagulant and procoagulant activities that might lead to concurrent thrombosis, bleeding disorders and disseminated intravascular coagulation. In addition, their toxins can produce edema, vasoconstriction, and tissue necrosis due to both direct cellular destruction and vascular injury around the bite site (8, 20, 21) .
Usually, local symptoms of snakebites comprise swelling (generally within two hours), pain, soreness of regional lymph nodes, bruises and necrosis on the bite site, as well as occasionally development of compartment syndrome (9, 10, 20) . In the current work, the manifestations of snake envenomations included local symptoms such as edema, local pain, hyperemia, numbness and compartment syndrome.
In Turkey, systemic symptoms of snake envenomations previously reported consisted of: epistaxis; hematemesis; ecchymosis; hemoptysis; subconjunctival, retroperitoneal and intracranial hemorrhages; ptosis; weakness; paresthesia; dysphagia; sweating; respiratory depression; paralysis; myotoxicity related symptoms; disseminated intravascular coagulation; and acute renal failure (8, 10, 13, 18, (20) (21) (22) (23) (24) (25) (26) (Figure 4) .
In the present study, systemic symptoms comprised: nausea; vomiting; hypotension; paresthesia; generalized edema; tachycardia; dyspnea; cyanosis; lethargy; dry mouth; ecchymosis; hematoma; circulation and hepatic failures; confusion; convulsions and thrombocytopenia. These findings strongly indicate that most envenomations result in hematological, neurotoxic, and myotoxic complications.
In our work, which corroborates an earlier report, 32.38% of the envenomation cases were classified as mild, 53.33% were moderate, and only less than 5% were considered severe (19) .
The specific treatment for envenomations due to snakebites is the administration of speciesspecific antivenom, which is widely employed in countries where snake attacks are frequent. There are three different antivenoms available in Turkey: European Viper Venom® (Intervax Biological, Canada) -a polyvalent antivenom against V. ammodytes, V. aspis, V. berus, V. lebetina, V. ursinii and V. xanthina venoms -is the most frequently used in the country; Pasteur Ipser Europe® (Pasteur Merieux, France) -a polyvalent antivenom against V. aspis, V. ammodytes and V. berus venoms -is also highly effective against several toxins; and finally, Polyvalent Snake Venom Antiserum® (Vacsera, Egypt) against V. ammodytes, V. lebetina and V. xanthina venoms) (14, 20) . Moreno et al. (19) reported that 16% of the patients affected by snake envenomations required antivenom treatment. In another study, antivenom was administered in 17 out of 24 patients (14) . In the present work, a significant number of patients was treated with antivenom (36%).
CONCLUSIONS
The epidemiological and clinical characteristics of snake envenomations throughout Turkey, between 1994 and 2005, were herein reported. These data clearly indicate that there are multiple species of medically important venomous snakes in the country. The findings also permit the comparison among cases of snake envenomations in different countries or regions, as well as the assessment of other types of accidents with poisonous animals, including scorpionism and marine envenomations. Based on our knowledge, it is evident that public awareness campaigns in Turkey and the increased number of healthcare facilities have kept to a minimum lethality due to envenomations. Furthermore, the offer of sufficient quantities of good quality antivenom to medical facilities in both rural and urban areas is crucial, as well as the maintenance of an adequate number of trained medical professionals in regions where snake envenomations are most common.
